In this article, we will take a look at the 5 Best Retirement Stocks to Buy Now. For a deeper discussion and an expanded list, please see 8 Best Retirement Stocks to Buy Now.
5. TotalEnergies SE (NYSE:TTE)
TotalEnergies SE (NYSE:TTE) ranks among the best retirement stocks to buy now. On May 13, UBS revealed its top picks among European energy companies, with TotalEnergies SE (NYSE:TTE) remaining the firm’s favored large-cap integrated energy play due to its healthy mix of operational resilience, capital management, and return on equity.
UBS cited the company’s substantial downstream and trading exposure as a significant advantage in a turbulent commodity market. The firm also notes price support, citing the stock’s anticipated 11.6% organic free cash flow return for 2026 and fairly low leverage.
Moreover, on April 29, TotalEnergies SE (NYSE:TTE) published strong earnings results for Q1 2026, with an adjusted net income of €5.4 billion, a considerable rise over the prior year. The company’s upstream division experienced 4% organic growth in production, exceeding its yearly forecast. The integrated LNG division also experienced considerable growth, with a 12% quarter-over-quarter increase in output.
TotalEnergies SE (NYSE:TTE) also gave forward guidance, with EPS estimates for future quarters ranging from $2.49 to $2.95. The company expects significant returns from its LNG projects, especially in Mozambique and Papua, which are projected to increase portfolio stability by 2029.
In a separate vein, TotalEnergies SE (NYSE:TTE) has approved final commitment and obtained funding for a 1 GW wind farm and battery storage facility in Southeastern Kazakhstan. The ‘Mirny Project’ encompasses 150 wind turbines and a 600 MWh battery storage system provided by TotalEnergies’ associate Saft. According to the company, the project will yield 100 TWh of green power over a 25-year period.
TotalEnergies SE (NYSE:TTE) is a global multi-energy company that produces and markets oil, biofuels, natural gas, renewables, and electricity.
4. AT&T Inc. (NYSE:T)
AT&T Inc. (NYSE:T) ranks among the best retirement stocks to buy now. According to a news release on May 21, AT&T Inc. (NYSE:T) launched Build-A-Plan, a wireless service that allows users to customize their plan monthly depending on their requirements and budget.
The plan will be accessible online beginning May 27 at a base price of $15 per month, including taxes and other charges. The telecommunications operator noted that the idea fulfills customer demand for financial versatility in wireless coverage.
The day prior, AT&T Inc. (NYSE:T) declared that it would invest $19 billion in California’s wireless and fiber networks through 2030.
By the end of 2030, the telecom company intends to build over 1,200 new cell sites around the state and provide fiber internet to over 4 million more houses and companies. The investment is $3 billion higher than what the company spent in California over the preceding five years, from 2021 to 2025.
AT&T Inc. (NYSE:T) is a global telecommunications and technology services provider. It provides 4G/5G-enabled wireless, fiber ethernet, broadband, managed professional services, and business solutions. It has two distinct segments, i.e., Communications and Latin America.
3. AbbVie Inc. (NYSE:ABBV)
AbbVie Inc. (NYSE:ABBV) ranks among the best retirement stocks to buy now. Piper Sandler increased its price target for AbbVie Inc. (NYSE:ABBV) to $298 from $294 on May 14, retaining an Overweight rating on the company’s shares. The firm mentioned AbbVie’s extensive inflammatory bowel disease pipeline as a major source of investor interest.
AbbVie Inc. (NYSE:ABBV) submitted 18 abstracts on inflammatory bowel illnesses at the 2026 Digestive Disease Week Annual Meeting, which was held in Chicago from May 2 to 5. The research centered around real-world evidence and long-term results for the company’s Crohn’s disease and ulcerative colitis therapies, SKYRIZI and RINVOQ.
The presentation featured 52-week follow-up results from the ASPIRE-CD study, which demonstrated that risankizumab-treated individuals with moderately to highly active Crohn’s disease had long-lasting improvements in liquid stools, bowel urgency, and abdominal pain.
Piper Sandler stated that management’s pursuit of novel combination methods in IBD is a positive development, considering the competitiveness of the IBD medication development landscape. According to the firm, one factor that makes AbbVie Inc. (NYSE:ABBV) appealing is the variety of R&D shots-on-goal that stay beneath the radar of the general investment market.
AbbVie Inc. (NYSE:ABBV) is a research-based biopharmaceutical company that researches & develops, manufactures, commercializes, and sells medicines and therapies worldwide.
2. Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) ranks among the best retirement stocks to buy now. On May 4, BMO Capital restated its Market Perform rating for Bristol-Myers Squibb Company (NYSE:BMY) while keeping a $60 price target on the company’s shares. The firm stated that near-term clinical results will affect market assumptions post-legacy product loss of exclusivity incidents.
The rating came after Bristol-Myers Squibb’s first-quarter revenue and earnings exceeded analyst projections. The company’s EPS of $1.58 exceeded market projections of $1.42, while its revenue of $11.49 billion crossed the consensus estimate of $10.92 billion. Year-over-year, total revenue increased by 3%, or 1% when currency effects are ruled out.
The company’s Growth Portfolio earned $6.2 billion, up 12%, primarily driven by Camzyos, Breyanzi, and Reblozyl.
BMO Capital now forecasts 2026 revenue of $16.4 billion, up from $16.1 billion previously, indicating slower depreciation. That said, the company’s pipeline to bridge revenues is under some pressure due to the generic entry of Revlimid and Pomalyst, Eliquis’ loss of exclusivity, and losses in IRA-related revenue.
Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company focused on discovering, developing, and delivering medicines for patients with serious diseases, including cancer, blood disorders, immune conditions, cardiovascular disease, and neurological disorders.
1. Chevron Corporation (NYSE:CVX)
Chevron Corporation (NYSE:CVX) ranks among the best retirement stocks to buy now. On May 5, RBC Capital maintained its Outperform rating on Chevron Corporation (NYSE:CVX) and set a $220 price target. The firm pointed out that although considerable free cash flow was projected in the coming months, Chevron decided to stick with its current strategy, capital structure, and payouts.
Meanwhile, UBS boosted Chevron Corporation (NYSE:CVX)’s price objective to $220 from $218, maintaining a Buy rating on the company’s shares. The firm referenced Chevron’s first-quarter 2026 earnings, which exceeded estimates despite timing-related hurdles.
The Middle East crisis had no direct impact on Chevron’s assets, and operations temporarily suspended for safety reasons have since resumed. Beyond the reversal of timing effects, UBS highlighted a number of possible earnings upside catalysts for the second and third quarters of 2026.
Notably, because the Tengiz-Chevroil project exceeds nameplate capacity, the firm anticipates volumes from Kazakhstan and Eurasia to increase by 60% in Q2 compared to Q1.
Chevron Corporation (NYSE:CVX) is a multinational energy company that explores, produces, refines, and sells oil and natural gas products, including transportation fuels and lubricants.
While we acknowledge the potential of CVX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CVX and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: Starter Stock Portfolio: 14 Safe Stocks to Buy Now and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
